Clinical Database and Biobank of Patients With Gynecologic Neoplasms

NCT01267851 | Unknown DMC

• 1 other identifier: GM2010-06-02
• Study Type: observational
• Target: 1,600,000
• Locations: 1 country
• Sites: 1

Brief Summary

The database and biobank establishment started in 1997 in our institute. However, the sample size was too small with respect to our clinical and fundamental scientific research's requirement. Thus the Chinese gynecological oncology study (GOS) group was established to create a large multicentre database and biobank of patients with gynecologic diseases.

Conditions

Cervical Cancer; Ovarian Cancer; Endometrial Cancer; Choriocarcinoma; Uterine Myoma; Endometriosis

Keywords

gynecologic disease

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

gynecologic diseases, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis, as well as part of population-based healthy women

You may qualify if:

• patients with informed consent;
• patients with gynecologic diseases;
• patients with intact clinical and pathological information

Sponsors & Collaborators

• Huazhong University of Science and Technology: lead
• Zhejiang University: collaborator
• Hunan Province Tumor Hospital: collaborator
• Guangxi Medical University: collaborator
• First Affiliated Hospital Xi'an Jiaotong University: collaborator
• West China Second University Hospital: collaborator
• Obstetrics & Gynecology Hospital of Fudan University: collaborator
• Shanghai First Maternity and Infant Hospital: collaborator
• Peking University People's Hospital: collaborator
• Wuhan Central Hospital: collaborator

Study Sites (1)

Tongji Hospital of HUST

Wuhan, Hubei, China

RECRUITING

Related Publications (1)

• Hu T, Li S, Chen Y, Shen J, Li X, Huang K, Yang R, Wu L, Chen Z, Jia Y, Wang S, Cheng X, Han X, Lin Z, Xing H, Qu P, Cai H, Song X, Tian X, Xu H, Xu J, Zhang Q, Xi L, Deng D, Wang H, Wang S, Lv W, Wang C, Xie X, Ma D. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria. Eur J Cancer. 2012 Oct;48(15):2353-60. doi: 10.1016/j.ejca.2012.03.015. Epub 2012 Apr 13.

  PMID: 22503395 DERIVED

MeSH Terms

Conditions

Uterine Cervical Neoplasms; Ovarian Neoplasms; Endometrial Neoplasms; Choriocarcinoma; Myofibroma; Endometriosis; Genital Diseases, Female

Condition Hierarchy (Ancestors)

Uterine Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Uterine Cervical Diseases; Uterine Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases; Endocrine Gland Neoplasms; Ovarian Diseases; Adnexal Diseases; Endocrine System Diseases; Gonadal Disorders; Trophoblastic Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Adenocarcinoma; Carcinoma; Neoplasms, Glandular and Epithelial; Pregnancy Complications, Neoplastic; Pregnancy Complications; Neoplasms, Connective Tissue; Neoplasms, Connective and Soft Tissue; Connective Tissue Diseases; Skin and Connective Tissue Diseases

Central Study Contacts

Ma Ding, M.D.

CONTACT

86-27-8362681; dma@tjh.tjmu.edu.cn

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director of the department of Obstetrics and Gynecology, Tongji Hospital

Study Record Dates

• First Submitted: December 28, 2010
• First Posted: December 29, 2010
• Study Start: January 1, 2010
• Primary Completion: December 30, 2019
• Study Completion: December 30, 2020
• Last Updated: July 19, 2019

Record last verified: 2019-07

Locations

CN (1)